期刊文献+

维持性血液透析患者双侧髂嵴皮下异位钙化肿块一例报告

Subcutaneous ectopic calcified lumps in bilateral iliac crests in the patient with maintaining blood dialysis: a case report
下载PDF
导出
摘要 矿物质与骨代谢紊乱(CKD-MBD)是慢性肾衰竭患者、特别是肾衰竭进行维持性血液透析(MHD)患者中的严重并发症。CKD-MBD可引起骨病及血管钙化,导致心血管事件高发,影响患者的生存质量。该文报道了1例MHD患者发现双侧髂嵴肿物,B超检查不能明确肿物性质,遂行局部活组织病理检查,结合生化指标,诊断为慢性肾功能不全引起的代谢性钙盐沉积症。经加强透析、控制饮食、口服不含钙的磷结合剂及活性维生素D等治疗措施后,双髂嵴肿块未见继续增大,且有逐步缩小趋势。 Mineral and bone metabolism disorder (CKD-MBD)is a serious complication in the pa-tients with chronic renal failure (CRF),particularly in CRF receiving maintenance blood dialysis. CKD-MBD may result in bone disease and vascular calcification,leading to a high incidence of cardiovascular events and then affecting the patient's quality of life. This article was reported a patient who having a maintenance dialysis showed lumps on bilateral iliac crests. B-ultrasound examination cannot determine the nature of the lumps.Based on the results of local tissue biopsy and biochemical laboratorial examinations,the diagnosis was made as metabolic calcium salt deposition,caused by chronic renal failure. After continuing dialysis,diet control as well as treatment with non-calcium-based phosphate binders and active vitamin D,the patient's lumps stopped increasing,and began to be narrowed gradually.
作者 徐政全
出处 《新医学》 2014年第3期204-206,共3页 Journal of New Medicine
关键词 血液透析 慢性肾脏病矿物质与骨代谢紊乱 异位钙化 Blood dialysis Mineral and bone metabolism disorder Ectopic calcification
  • 相关文献

参考文献4

二级参考文献19

  • 1陈香美,王海燕.提高慢性肾脏病的知晓率、治疗率和控制率减轻对国民健康的危害[J].中华内科杂志,2006,45(6):441-442. 被引量:65
  • 2Moe S, Drueke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int, 2006, 69: 1945-1953. 被引量:1
  • 3Kidney Disease: Improving Global Outcomes (KDIGO) CKD- MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD- MBD). Kidney Int Suppl, 2009, 113: S1-S130. 被引量:1
  • 4National Kidney Foundation. K/DOQ1 clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis, 2003, 42 (4 Suppl 3): S1 -S201. 被引量:1
  • 5Kidney Disease:Improving Global Outcomes(KDIGO)CKD-MBD fork Group.KDIGO clinical practice guideline for the diagnosis,evaluation,prevention,and treatment of Chronic Kidney Disease-Mineral and Bone Disorder(CKD-MBD)[J].Kidney Int Suppl,2009:S1-130. 被引量:1
  • 6National Kidney Foundation.K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease[J].Am J Kidney Dis,2003,42:S1-201. 被引量:1
  • 7Spasovski GB,Bervoets AR,Behets GJ,et al.Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis[J].Nephrol Dial Transplant,2003,18:1159-1166. 被引量:1
  • 8Klawansky S,Komaroff E,Cavanaugh PF,Jr.,et al.Relationship between age,renal function and bone mineral density in the US population[J].Osteoporos Int,2003,14:570-576. 被引量:1
  • 9Alem AM,Sherrard DJ,Gillen DL,et al.Increased risk of hip fracture among patients with end-stage renal disease[J].Kidney Int,2000,58:396-399. 被引量:1
  • 10Jamal SA,Bauer DC,Ensrud KE,et al.Alendronate treatment in women with normal to severely impaired renal function:an analysis of the fracture intervention trial[J].J Bone Miner Res,2007,22:503-508. 被引量:1

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部